Impact of a conjugate vaccine on community-wide carriage of nonsusceptible Streptococcus pneumoniae in Alaska.
about
Baseline meningococcal carriage in Burkina Faso before the introduction of a meningococcal serogroup A conjugate vaccineThe anticipated severity of a "1918-like" influenza pandemic in contemporary populations: the contribution of antibacterial interventionsEffect of the 13-valent pneumococcal conjugate vaccine on nasopharyngeal colonization by Streptococcus pneumoniae--Alaska, 2008-2012.Molecular characterization of Streptococcus pneumoniae serotype 12F isolates associated with rural community outbreaks in AlaskaBetween-strain competition in acquisition and clearance of pneumococcal carriage--epidemiologic evidence from a longitudinal study of day-care children.Impact of a pneumococcal conjugate vaccination program on carriage among children in Norway.Efficacy of 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine against acute otitis media and nasopharyngeal carriage in Panamanian children - A randomized controlled trialProtein carriers of conjugate vaccines: characteristics, development, and clinical trials.Pneumococcal nasopharyngeal carriage following reduced doses of a 7-valent pneumococcal conjugate vaccine and a 23-valent pneumococcal polysaccharide vaccine boosterEmergence of Streptococcus pneumoniae serogroups 15 and 35 in nasopharyngeal cultures from young children with acute otitis media.Cost-effectiveness of new pneumococcal conjugate vaccines in Turkey: a decision analytical model.Nasopharyngeal carriage, serotype distribution and antimicrobial resistance of Streptococcus pneumoniae among children from Brazil before the introduction of the 10-valent conjugate vaccineTime is (still) of the essence: quantifying the impact of emergency meningitis vaccination response in Katsina State, Nigeria.Optimising assessments of the epidemiological impact in The Netherlands of paediatric immunisation with 13-valent pneumococcal conjugate vaccine using dynamic transmission modelling.The serotype distribution among healthy carriers before vaccination is essential for predicting the impact of pneumococcal conjugate vaccine on invasive disease.Seasonality of Pneumococcal Nasopharyngeal Carriage in Rural Gambia Determined within the Context of a Cluster Randomized Pneumococcal Vaccine TrialPneumococcal nasopharyngeal carriage in children <5 years of age visiting the pediatric emergency room in relation to PCV7 and PCV13 introduction in southern IsraelCommunity prescribing and resistant Streptococcus pneumoniae.Changes in serotype distribution and antibiotic resistance of nasopharyngeal isolates of Streptococcus pneumoniae from children in Korea, after optional use of the 7-valent conjugate vaccine.An outbreak of pneumococcal meningitis among older children (≥5 years) and adults after the implementation of an infant vaccination programme with the 13-valent pneumococcal conjugate vaccine in Ghana.Geographic variation in pneumococcal vaccine efficacy estimated from dynamic modeling of epidemiological data post-PCV7Changes in serotypes and antimicrobial susceptibility of invasive Streptococcus pneumoniae strains in Cleveland: a quarter century of experience.Pneumococcal conjugate vaccines: emerging clinical information and its implications.Nasopharyngeal colonization: a target for pneumococcal vaccination.Pneumococcal conjugated vaccines: impact of PCV-7 and new achievements in the postvaccine era.Nasopharyngeal pneumococcal carriage rates among HIV-infected adults following widespread pediatric use of conjugate pneumococcal vaccine-13.Efficacy and effectiveness of extended-valency pneumococcal conjugate vaccines.New patterns in the otopathogens causing acute otitis media six to eight years after introduction of pneumococcal conjugate vaccine.Streptococcus pneumoniae serotype 19A: Worldwide epidemiology.Nasopharyngeal bacterial carriage in young children in Greenland: a population at high risk of respiratory infections.Long-term effects of penicillin resistance and fitness cost on pneumococcal transmission dynamics in a developed setting.Changes in the Serotype Distribution among Antibiotic Resistant Carriage Streptococcus pneumoniae Isolates in Children after the Introduction of the Extended-Valency Pneumococcal Conjugate Vaccine.Changes in pneumococcal nasopharyngeal colonization among children with respiratory tract infections before and after use of the two new extended-valency pneumococcal conjugated vaccines.Trends in invasive pneumococcal disease (IPD) in cancer patients after the introduction of 7-valent pneumococcal conjugate vaccine (PCV7): A 20-year longitudinal study at a major urban cancer center.Nasopharyngeal carriage of Streptococcus pneumoniae in healthy Turkish children after the addition of PCV7 to the national vaccine schedule.Serotype specific invasive capacity and persistent reduction in invasive pneumococcal diseaseEpidemiology of pneumococcal serotype 6A and 6C among invasive and carriage isolates from Alaska, 1986-2009.Pneumococcal serotype distribution in invasive paediatric disease in Southern Finland before the introduction of vaccine.Antimicrobial resistance trends among sinus isolates of Streptococcus pneumoniae in the United States (2001-2005).Determining the pneumococcal conjugate vaccine coverage required for indirect protection against vaccine-type pneumococcal carriage in low and middle-income countries: a protocol for a prospective observational study.
P2860
Q24629949-F2BA8DE8-742E-4390-801F-FF077FB17845Q28732491-E765F668-4C47-4074-BD46-F91ED972DFC9Q30218803-1701FB57-1D21-4A4E-9597-9F91E2FA991BQ30539635-40241F24-09CC-4B6A-80DA-02C08C91CE89Q33566530-DC4A97D8-89B5-4D80-B907-0F538CF63699Q33725199-E6BA9C14-365F-40DE-B0B4-64FBAA916A9BQ33848675-8F418DF1-5755-470F-A1F7-8CB8FDBB4452Q34170021-29F0948F-177A-42ED-8C8E-E2CA045CADF8Q34431928-14129B15-0D1E-48B1-8D3C-59E0134F027BQ34437679-9F6AFCBF-1E37-4F78-949B-7449CA604BBBQ34471089-AF623544-DAE9-4D9E-A511-1F85C7D86E65Q34815797-76FCE871-6AB2-49C6-B88C-D69658B2D2D1Q35029246-119CA7A5-E7AC-4DAD-8467-88B4BE49A7FBQ35138184-9E062C51-0E6D-4578-BD71-6434F2C8BB58Q35603351-DA14EE84-3321-4402-A1B6-FB1BFA8B1251Q35679931-64E9D174-6996-42E2-AE43-FA594E0A6FB2Q35796784-000A5048-8A3D-4FA0-9B5A-65C022584366Q36009361-C8C0ED4F-DC3E-4546-8B0F-67D81507AED7Q36079013-A2FF291B-C09B-4E42-A4EC-E53D9D0B6CC6Q36166629-8EF44259-834E-4BB7-9F5B-80D29C1F336DQ36399999-B4F92769-96C8-4298-9526-D3E17442FDE8Q36497899-F5B3CD34-10C6-4493-B297-E6299D932578Q36600371-EB74B720-2E1F-4EA5-9886-CB97E1E969CAQ36689018-3D6973C4-12E5-4301-B2B8-A40CC58DCDB0Q37316015-A4C9F557-44A1-4D36-9B41-1E1560531D20Q37357919-6F28E757-0684-4159-8990-817AE9D73B77Q37663184-0C97DDF6-572F-4181-9630-2BA50281AED5Q38363735-D22419F5-F885-4B79-9707-8F13EBBE763BQ38637072-5542F16A-B580-4DB2-B458-52FB096F539FQ38842679-DAD4F334-83BE-4DE2-ABCC-E449CDFB75B1Q38864607-BCBB5EAC-93F2-486E-822A-4FEE135B28B3Q41285540-D6454C53-158B-44AA-9582-590F6A4512AEQ41465610-7ACC33CB-BF34-4126-B1E1-0EEA3B62148CQ41987062-E5D54416-83F5-420F-AA28-378F18D78A8CQ42247332-2E09E22F-0EB5-49DD-BD02-13A01A7FE5EBQ42829056-88FFE8FA-ADDB-4957-8967-13B5D9078C63Q43192562-E3FEE0E6-D22F-4B41-83F2-83C8DD443EC7Q44946598-D196DD6C-FBB0-4813-9AB4-76014A4B2C3CQ48917114-288D4931-38FC-400A-B17D-6029471BA8F1Q54206312-5F42843D-1871-4E7E-A926-78EF30695F2E
P2860
Impact of a conjugate vaccine on community-wide carriage of nonsusceptible Streptococcus pneumoniae in Alaska.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Impact of a conjugate vaccine ...... tococcus pneumoniae in Alaska.
@en
Impact of a conjugate vaccine ...... tococcus pneumoniae in Alaska.
@nl
type
label
Impact of a conjugate vaccine ...... tococcus pneumoniae in Alaska.
@en
Impact of a conjugate vaccine ...... tococcus pneumoniae in Alaska.
@nl
prefLabel
Impact of a conjugate vaccine ...... tococcus pneumoniae in Alaska.
@en
Impact of a conjugate vaccine ...... tococcus pneumoniae in Alaska.
@nl
P2093
P50
P356
P1476
Impact of a conjugate vaccine ...... tococcus pneumoniae in Alaska.
@en
P2093
Alan Parkinson
Alisa L Reasonover
Debra J Parks
James Gove
Jay C Butler
Karen Rudolph
Marcella Harker-Jones
Matthew R Moore
Terri B Hyde
P304
P356
10.1086/425422
P407
P577
2004-10-27T00:00:00Z